RxDoctor Payments Data

Thomas Terramani, MD

Vascular Surgery · la Mesa, CANPI 1447344338

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $90,521 of the $126,487 with a category attached, or 71.6%. 38 manufacturers reported payments, led by Novapproach Spine, LLC at 30.4% of the total. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,487in general payments, 2019–2025

Across 169 payments — averaging $748.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novapproach Spine, LLC$38K
  • Aesculap Implant Systems, LLC$24K
  • Kyocera Medical Technologies, Inc.$21K
  • Medical Device Business Services, Inc.$11K
  • Medtronic$10K
  • Stryker$9K
  • plus $14K from 32 others

What the payments were for

  • Royalty or licence$6,3275%
  • Consulting fees$90,52172%
  • Speaking & faculty fees$17,64714%
  • Travel & lodging$6,7925%
  • Food & beverage$5,0874%
  • Other$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,487 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California

Medicare billing

Part B allowed, 2024
$87,243
Medicare patients
547
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in la Mesa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →